Spots Global Cancer Trial Database for Precise Treatment in Hepatobiliary Cancers (PTHBC)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Precise Treatment in Hepatobiliary Cancers (PTHBC)

Official Title: Single Center, Single Arm, Open Study, to Explore and Evaluate the Precise Treatment in Hepatobiliary Cancers(PTHBC)

Study ID: NCT02715089

Conditions

Liver Neoplasms

Biliary Tract Neoplasms

Hepatobiliary Neoplasms

Interventions

Precise treatment

Study Description

Brief Summary: The purpose of this study is to explore the precise treatment in hepatobiliary cancer patients and evaluate drug safety, progression free and overall survival. This trial study is based on genetic tests, then therapeutic target drugs are administered according to the genetic test reports. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit from precise treatment which targets particular genetic abnormality. The identifications of these genetic abnormalities may help treat hepatobiliary cancer patients better.

Detailed Description: The genetic tests are performed for the eligible subjects in this study, then therapeutic target drugs are administered according to the genetic test reports. While the precise treatments, follow-ups are conducted to evaluate the efficacy and safety of the target drugs for the subjects, until the overall survival. Study Type: Non-Interventional. Masking: Open Label.